BioNTech SE BNTX
NASDAQ BNTX
$91.88 +0.71 (+0.77%)
As of: Oct 21, 2026 · 2:41 PM EDT

BioNTech SE (BNTX) Equity Income (2018)

Updated

BioNTech SE (BNTX) posted Equity Income of -$99,232 for FY2018, compared with -$88,088 in FY2017.

Analysis

BioNTech SE (BNTX) Equity Income (2018) Analysis & Trends

  • Business Quant data shows BNTX's Equity Income at -$88,088 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn -
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn -
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn -10.00 Mn
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn -
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn -
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn -
10 BioNTech SE 22.19 Bn -24.28 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -24,425.71
API Access

BioNTech SE Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=BNTX&period=max&api_key=YOUR_API_KEY